Amerikanische Gesellschaft für Hirudotherapie

Arterial and venous revascularization with bifurcation of a single central artery: a reliable strategy for Tamai Zone I replantation

Case series published in Plast Reconstr Surg (2010)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportKlinische StudienHsu CC et al. · Plastic and reconstructive surgery, 2010

Abstract

BACKGROUND: Replantation of the distal phalanx and pulp can be performed to improve finger function and finger aesthetics; however, establishing adequate venous drainage is a challenge. Slattery et al. reported microsurgical reattachment of a partial distal phalanx with the use of a bifurcated terminal digital artery. The bifurcation was divided into two pedicles, one of which was used for venous drainage. In this article, the authors report their experience with a similar technique and propose a new algorithm for distal finger replantation. METHODS: From January of 2008 to February of 2009, five replantations were performed using a single central artery. The replanted levels were pulp, avulsed fingertip of the thumb, and distal phalanges. There was no volar vein, dorsal vein, or second artery available in the amputated part for standard venous drainage. Venous drainage in all cases was established by creating an anastomosis from a branch of the solitary terminal artery to a recipient vein. RESULTS: All digits were replanted successfully without evidence of arterial insufficiency or venous congestion. Partial necrosis was not identified postoperatively in any of the five fingers. There were no cases of wound infection. CONCLUSIONS: A branch of the central solitary artery may be used successfully to reestablish venous outflow in cases of distal finger tip replantation. This technique allowed for the salvage of all fingers in this study without the use of leeches or other techniques used in cases of venous insufficiency.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsAdultAmputation, TraumaticArteriesChild, PreschoolFemaleFinger InjuriesFingersHumansMaleMicrosurgeryMiddle AgedReplantation

Zusammenfassung

Five distal-phalanx replants using a single central artery bifurcated into one arterial and one venous pedicle, with anastomosis to a recipient vein. All digits survived without leeches or other venous-congestion techniques — proposes a new algorithm for distal finger replantation.

Warum dies für die Hirudotherapie relevant ist

This case report describes five distal finger replantations in which venous outflow was established by anastomosing a branch of a single central artery to a recipient vein when no standard vein or second artery was available. All five digits were successfully replanted without arterial insufficiency, venous congestion, partial necrosis, or wound infection, and without using leeches or other venous-insufficiency techniques. This is relevant to ASH because distal replantation venous congestion is a setting where medicinal leeches are often considered, and the technique is proposed as a leech-sparing option. The findings are limited to a very small case report, with no comparative assessment of leech therapy or detailed longer-term outcomes in the abstract.

Zitation

Arterial and venous revascularization with bifurcation of a single central artery: a reliable strategy for Tamai Zone I replantation.

Hsu CC et al. · Plastic and reconstructive surgery, 2010

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 26, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.